Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation
Identifiers
Identifiers
Date issued
2012Journal title
LIVER TRANSPLANTATION
Type of content
Artigo